Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Zivanovic

Showing results (141-150 of 204) with videos related to

Pageof 21
Sort By:
Gynecologic Oncology|January 23, 2024
Regionalizing ovarian cancer cytoreduction to high-volume centers and the impact on patient travel in New York StateRyan M Kahn, Xiaoyue Ma, Sushmita Gordhandas, et al.
Gynecologic Oncology|June 11, 2020
A multimodality triage algorithm to improve cytoreductive outcomes in patients undergoing primary debulking surgery for advanced ovarian cancer: A Memorial Sloan Kettering Cancer Center team ovary initiativeAlli M Straubhar, Olga T Filippova, Renee A Cowan, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 27, 2020
Pre-operative neoadjuvant chemotherapy cycles and survival in newly diagnosed ovarian cancer: what is the optimal number? A Memorial Sloan Kettering Cancer Center Team Ovary studyYing L Liu, Qin C Zhou, Alexia Iasonos, et al.
Gynecologic Oncology|June 16, 2019
Secondary surgical resection for patients with recurrent uterine leiomyosarcomaPaulina Cybulska, Vasileios Sioulas, Theofano Orfanelli, et al.
Gynecologic Oncology|November 24, 2022
Association of bowel preparation with surgical-site infection in gynecologic oncology surgery: Post-hoc analysis of a randomized controlled trialLea A Moukarzel, Nguyen Nguyen, Qin Zhou, et al.
Annals of Surgical Oncology|February 25, 2016
Impact of Obesity on Sentinel Lymph Node Mapping in Patients with Newly Diagnosed Uterine Cancer Undergoing Robotic SurgeryAne Gerda Zahl Eriksson, Margaret Montovano, Anna Beavis, et al.
Gynecologic Oncology|July 27, 2021
Risk of venous thromboembolism in ovarian cancer patients receiving neoadjuvant chemotherapyDerman Basaran, Thomas Boerner, Jessa Suhner, et al.
Gynecologic Oncology|July 16, 2023
Leave it in the past - primary treatment modality for high-grade epithelial ovarian cancer is not associated with secondary cytoreduction outcomes: A Memorial Sloan Kettering Cancer Center Team Ovary studyTiffany Y Sia, Beryl L Manning-Geist, Sarah Ehmann, et al.
Gynecologic Oncology|February 18, 2017
A multicenter assessment of the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease at primary debulking for advanced epithelial ovarian cancerRudy S Suidan, Pedro T Ramirez, Debra M Sarasohn, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 22, 2020
Comparison of minimally invasive versus open surgery in the treatment of endometrial carcinosarcomaSilvana Pedra Nobre, Jennifer J Mueller, Ginger J Gardner, et al.
Pageof 21

Showing results (141-150 of 204) with videos related to

Sort By:
Pageof 21
Gynecologic Oncology|January 23, 2024
Regionalizing ovarian cancer cytoreduction to high-volume centers and the impact on patient travel in New York StateRyan M Kahn, Xiaoyue Ma, Sushmita Gordhandas, et al.
Gynecologic Oncology|June 11, 2020
A multimodality triage algorithm to improve cytoreductive outcomes in patients undergoing primary debulking surgery for advanced ovarian cancer: A Memorial Sloan Kettering Cancer Center team ovary initiativeAlli M Straubhar, Olga T Filippova, Renee A Cowan, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 27, 2020
Pre-operative neoadjuvant chemotherapy cycles and survival in newly diagnosed ovarian cancer: what is the optimal number? A Memorial Sloan Kettering Cancer Center Team Ovary studyYing L Liu, Qin C Zhou, Alexia Iasonos, et al.
Gynecologic Oncology|June 16, 2019
Secondary surgical resection for patients with recurrent uterine leiomyosarcomaPaulina Cybulska, Vasileios Sioulas, Theofano Orfanelli, et al.
Gynecologic Oncology|November 24, 2022
Association of bowel preparation with surgical-site infection in gynecologic oncology surgery: Post-hoc analysis of a randomized controlled trialLea A Moukarzel, Nguyen Nguyen, Qin Zhou, et al.
Annals of Surgical Oncology|February 25, 2016
Impact of Obesity on Sentinel Lymph Node Mapping in Patients with Newly Diagnosed Uterine Cancer Undergoing Robotic SurgeryAne Gerda Zahl Eriksson, Margaret Montovano, Anna Beavis, et al.
Gynecologic Oncology|July 27, 2021
Risk of venous thromboembolism in ovarian cancer patients receiving neoadjuvant chemotherapyDerman Basaran, Thomas Boerner, Jessa Suhner, et al.
Gynecologic Oncology|July 16, 2023
Leave it in the past - primary treatment modality for high-grade epithelial ovarian cancer is not associated with secondary cytoreduction outcomes: A Memorial Sloan Kettering Cancer Center Team Ovary studyTiffany Y Sia, Beryl L Manning-Geist, Sarah Ehmann, et al.
Gynecologic Oncology|February 18, 2017
A multicenter assessment of the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease at primary debulking for advanced epithelial ovarian cancerRudy S Suidan, Pedro T Ramirez, Debra M Sarasohn, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 22, 2020
Comparison of minimally invasive versus open surgery in the treatment of endometrial carcinosarcomaSilvana Pedra Nobre, Jennifer J Mueller, Ginger J Gardner, et al.
Pageof 21